Synopsys (SNPS) Valuation Check As Recent Returns Ease And Ansys Deal Shapes Expectations

Recent performance context for Synopsys (SNPS)

Without a specific news catalyst, Synopsys (SNPS) has still been on many investors' radars, given its recent share performance and its role supplying design and IP tools to the semiconductor and electronics industries.

See our latest analysis for Synopsys.

At a share price of US$432.98, Synopsys has seen its 90 day share price return of 9.28% and year to date share price return of 9.87% contrast with a 5 year total shareholder return of 83.77%. This suggests recent momentum has cooled compared with its longer track record.

If Synopsys has you thinking more broadly about software and chip design trends, this could be a good moment to scan 35 AI infrastructure stocks for potential ideas that fit a similar theme.

With Synopsys trading around US$432.98 and recent returns softer than its 3 and 5 year record, along with mixed signals on value scores and intrinsic estimates, is this a mispriced entry point or is the market already accounting for future growth?

Most Popular Narrative: 19.5% Undervalued

With Synopsys last closing at $432.98 against a most followed fair value estimate of $537.75, the narrative frames the stock as materially mispriced and emphasizes how the Ansys combination and business mix shift could reshape its financial profile over the next few years.

The ongoing transformation towards SaaS/cloud-based EDA and Ansys product integration is expected to increase customer stickiness and shift more revenues to subscription and service models, improving revenue visibility and earnings consistency, this directly addresses operational headwinds and is likely underappreciated if the stock is undervalued.

Read the complete narrative.

Curious what sort of revenue growth, margin uplift and future earnings multiple need to line up for that fair value to hold? The narrative focuses on ambitious profit compounding, a richer mix of recurring SaaS and IP revenue, and a premium P/E usually reserved for high growth software leaders. If you want to see the exact assumptions behind that view, the full narrative lays them out in black and white.

Result: Fair Value of $537.75 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, the story could change quickly if China related export restrictions deepen or if Ansys integration costs and execution issues weigh more heavily on earnings.

Find out about the key risks to this Synopsys narrative.

Another Take On Synopsys' Valuation

The narrative you have just read leans on future earnings power to argue Synopsys is 19.5% undervalued. Today the stock trades on a P/E of 75x versus a fair ratio of 43.5x, the US Software average of 28.1x and a peer average of 41.1x. This points to a rich valuation and raises the question: how comfortable are you paying this kind of premium for execution on that story?

See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

If this mix of optimism and concern feels finely balanced, now is a good time to review the numbers yourself and stress test both sides of the argument, starting with 2 key rewards and 3 important warning signs.

Looking for more investment ideas?

If Synopsys has sharpened your thinking, do not stop here. This is the moment to widen your watchlist and line up your next few ideas.

• Target resilient value by scanning 50 high quality undervalued stocks that combine solid fundamentals with prices that may not fully reflect their underlying strength.
• Strengthen your income stream with 14 dividend fortresses built around companies offering higher yields with an emphasis on stability.
• Spot potential early movers through our screener containing 23 high quality undiscovered gems and get ahead of ideas that fewer investors are watching closely.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com